Visgeneer (TWO:4197) — Market Cap & Net Worth
Market Cap & Net Worth: Visgeneer (4197)
Visgeneer (TWO:4197) has a market capitalization of $8.09 Million (NT$256.84 Million) as of August 3, 2026. Listed on the TWO stock exchange, this Taiwan-based company holds position #27554 globally and #1587 in its home market, demonstrating a -6.48% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Visgeneer's stock price NT$8.51 by its total outstanding shares 30181000 (30.18 Million). See Visgeneer (4197) capital reinvestment to understand how much of operating cash flow is reinvested back into capital assets.
Visgeneer Market Cap History: 2015 to 2026
Visgeneer's market capitalization history from 2015 to 2026. Data shows change from $26.63 Million to $8.09 Million (-7.69% CAGR).
Visgeneer Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Visgeneer's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.05x
Visgeneer's market cap is 0.05 times its annual revenue
Latest Price to Earnings (P/E) Ratio
1.76x
Visgeneer's market cap is 1.76 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $12.40 Million | $163.01 Million | $381.00K | 0.08x | 32.54x |
| 2017 | $12.73 Million | $157.61 Million | -$30.66 Million | 0.08x | N/A |
| 2018 | $9.98 Million | $142.54 Million | -$31.89 Million | 0.07x | N/A |
| 2019 | $12.79 Million | $151.99 Million | -$31.75 Million | 0.08x | N/A |
| 2020 | $13.50 Million | $175.96 Million | $603.00K | 0.08x | 22.39x |
| 2021 | $12.17 Million | $165.29 Million | $820.00K | 0.07x | 14.84x |
| 2022 | $10.27 Million | $157.96 Million | $12.35 Million | 0.07x | 0.83x |
| 2023 | $9.98 Million | $147.99 Million | -$19.59 Million | 0.07x | N/A |
| 2024 | $9.29 Million | $115.76 Million | -$17.73 Million | 0.08x | N/A |
| 2025 | $9.22 Million | $179.06 Million | $5.25 Million | 0.05x | 1.76x |
Competitor Companies of 4197 by Market Capitalization
Companies near Visgeneer in the global market cap rankings as of August 3, 2026.
Key companies related to Visgeneer by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #220 globally with a market cap of $110.45 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #424 globally with a market cap of $64.60 Billion USD.
- Argen-X (BR:ARGX): Ranked #543 globally with a market cap of $49.55 Billion USD ( €42.38 Billion EUR).
- UCB SA (BR:UCB): Ranked #563 globally with a market cap of $47.34 Billion USD ( €40.49 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #220 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $110.45 Billion | $477.10 |
| #424 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $64.60 Billion | $762.63 |
| #543 | Argen-X | BR:ARGX | $49.55 Billion | €745.00 |
| #563 | UCB SA | BR:UCB | $47.34 Billion | €222.90 |
Visgeneer Historical Marketcap From 2015 to 2026
Between 2015 and today, Visgeneer's market cap moved from $26.63 Million to $ 8.09 Million, with a yearly change of -7.69%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$8.09 Million | -12.27% |
| 2025 | NT$9.22 Million | -0.72% |
| 2024 | NT$9.29 Million | -6.95% |
| 2023 | NT$9.98 Million | -2.78% |
| 2022 | NT$10.27 Million | -15.62% |
| 2021 | NT$12.17 Million | -9.86% |
| 2020 | NT$13.50 Million | +5.58% |
| 2019 | NT$12.79 Million | +28.10% |
| 2018 | NT$9.98 Million | -21.58% |
| 2017 | NT$12.73 Million | +2.68% |
| 2016 | NT$12.40 Million | -53.44% |
| 2015 | NT$26.63 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 2nd, 2026 the market cap of Visgeneer was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $8.09 Million USD |
| MoneyControl | $8.09 Million USD |
| MarketWatch | $8.09 Million USD |
| marketcap.company | $8.09 Million USD |
| Reuters | $8.09 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Visgeneer
Visgeneer Inc. provides health solutions in the fields of medical device, cosmetics and skin care, Zeaxanthin, and cancer gene diagnostics in Europe and Asia. The company offers blood glucose and ketone, uric acid, and cholesterol monitoring systems. It also provides functional masks, such as wood pulp mask, invisible mask, black mask, pure cloth mask, and bio cellulose mask; face cream, night cr… Read more